GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pharmather Holdings PHRM.CN · CAD

N/A · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.05

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2026

Net income

−C$610,438

FY2019FY2026

Free cash flow

−C$485,007

FY2019FY2026

Shareholders' equity

C$613,106

FY2019FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2019
Research and developmentC$148,142C$581,600C$2.1mC$3.0mC$2.6mC$751,535—
Operating income−C$845,952−C$1.6m−C$3.1m−C$4.0m−C$4.1m−C$2.8m−C$7,200
Net income−C$610,438−C$1.5m−C$3.1m−C$6.4m−C$4.0mC$2.7m−C$7,200
Diluted earnings per share-0.01-0.02-0.04-0.07-0.040.03-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2019
Total assetsC$1.1mC$1.3mC$2.6mC$6.3mC$12.2mC$5.9mC$117,900
Cash and short-term investments—C$1.1m————C$13,300
Total liabilitiesC$509,141C$366,300C$252,901C$892,478C$330,318C$361,060C$7,600
Shareholders' equityC$613,106C$973,500C$2.3mC$5.4mC$11.8mC$5.6mC$110,300
Shares outstanding91m89m88m91m91m91m65m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2019
Cash from operations−C$485,007−C$1.2m−C$3.5m−C$3.2m−C$3.5mC$922,190−C$10,600
Capital spending—————−C$4,265—
Free cash flow−C$485,007−C$1.2m−C$3.5m−C$3.2m−C$3.5mC$917,925−C$10,600

Latest quarters

By quarter end

May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024
Operating income−C$87,087−C$212,454−C$211,031−C$335,380−C$535,900−C$357,457−C$346,293−C$329,137
Net incomeC$79,579−C$2,365−C$248,459−C$439,193−C$408,800−C$369,484−C$367,674−C$380,162
Diluted earnings per share0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assetsC$1.1mC$1.1mC$979,767C$1.3mC$1.3mC$1.5mC$1.8mC$2.2m
Cash and short-term investments————C$1.1m———
Shareholders' equityC$613,106C$533,527C$535,892C$784,351C$973,500C$1.2mC$1.6mC$2.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-40.5%-21.4%—
Net income-54.3%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings-7.5-6.1-3.3-2.4-0.86.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.